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THE ROLE OF SUB-CLINICAL PROSTATITIS ON BPH/LUTS PATIENTS
Kuan-Yu Wu, Yuh-Shyan Tsai, Hong-Lin Cheng, Chien-Hui Ou, Wen-Horng
Yang, Tzong-Shin Tzai. Department of Urology, National Cheng Kung
University Hospital, College of Medicine, National Cheng Kung University,
Tainan, Taiwan
Purpose: Subclinical prostatitis is a common ﬁnding in transrectal ultra-
sound (TRUS) biopsy specimens. In this study, we tried to compare the
difference between BPH and subclinical prostatitis.
Materials andMethods: From January 2013 to July 2015, total 125 patients
underwent 12-core prostate biopsy because of elevated PSA levels (>4 ng/
ml) or abnormal rectal examination. All of them received PSA, rectal ex-
amination, maximum ﬂow rate, voiding volume, PSA density, TZ index,
IPSS score, and quality of life questionnaires. We used unpaired t test and
Fisher test to compare the remaining mentioned above.
Results: After histopathological evaluation, 91patients (72.8%) were
diagnosed with BPH, while asymptomatic prostatitis and BPH were
detected in 34 patients (27.2%). Men with asymptomatic prostatitis
exhibited higher PSA density (0.26 vs. 0.17, p¼ 0.002) and lower quality of
life (p¼ 0.0428) than men with BPH. Contrastively, no signiﬁcant differ-
ence was observed between PSA, size of prostate, maximum ﬂow rate,
voiding volume, and total IPSS score.
Conclusion: Subclinical prostatitis patients experienced deteriorated
quality of life compared to BPH patients.
NDP052:
LUPUS CYSTITIS PRESENTING WITH LOWER URINARY TRACT
SYMPTOMS: A CASE REPORT
Kai-Yi Tzou, Yin-Ting Liu, Chi-Yun Lan, Su-Wei Hu, Chia-Chang Wu, Kuan-
Chou Chen. Department of Urology, Taipei Medical University-Shuang Ho
Hospital, New Taipei, Taiwan
Hemorrhagic cystitis is a rare manifestation of systemic lupus erythema-
tosus (SLE), but potentially life-threatening complication. We report a 45-
year-old manwith newly diagnostic SLE who suffered from irritative lower
urinary tract symptoms and gross hematuria. Cystoscopy revealed severe
diffuse inﬂammation, erythema and hemorrhage at the trigone with
punctate extensions to the posterior wall. Severe hemorrhagic cystitis
were diagnosed. Initially, he received medical treatment, frequent red
blood cell and platelet transfusions, continuous bladder irrigation, elec-
trocoagulation and blood clots evacuation. After he was treated with
prednisone, his symptoms and cystoscopy ﬁndings improved.
NDP053:
EJACULATORY DUCT OBSTRUCTION: A CASE REPORT AND REVIEW OF
THE LITERATURE
Chih-Yin Yeh, Guang-Dar Juang. Division of Urology, Department of Surgery,
Shin Kong WHS Memorial Hospital, Taiwan
Ejaculatory duct obstruction (EDO) presents with infertility, pain, or
hematospermia. Etiologically it can be either congenital or acquired. The
diagnosis of EDO mainly depends on history, physical examination and
semen analysis. The semen of EDO patients is characterized by low ejac-
ulate volume, oligospermia or azoospermia. Transrectal ultrasound has
replaced formal vasography as the ﬁrst-line diagnostic test but is not
speciﬁc. Transurethral resection of the ejaculatory ducts (TURED), as the
standard surgical method of treatment for EDO, and is effective for most of
the patients.
We present a 65 year-old male suffered from ejaculatory pain with low or
no semen volume for more than 10 years. Post-ejacualtion pain was chief
complained and beading vas was palpable on physical examination. He
also complained of suprapubic pain or orchialgia occasionally. Transrectal
ultrasound revealed dilated right ejaculatory duct with cystic formation
just in the verumontanum and dilated both seminal vesicles. Magnetic
resonance imaging (MRI) showed ejaculatory duct obstruction and semi-
nal vesicle enlargement. TURED revealed the dilated ejaculatory duct
oriﬁce and cyst cavity below the verumontanum. Large amount of semen-like ﬂuid ﬂew from the ejaculatory duct during operation. The pain on
ejaculation disappeared following treatment. The literature will be revie-
wed.
NDP054:
CASE REPORT: A GIANT ATONIC BLADDER WITH MORE THAN 5000ML
IN VOLUME
Yi-Bo Chu 1, Te-Fu Tsai 1,2, Thomas I.S. Hwang 1,2. 1Division of Urology,
Department of Surgery, Shin Kong WHS Memorial Hospital, Taiwan;
2 School of Medicine, Fu-Jen Catholic University, Taiwan
The urinary bladder is a structure with autonomic nerve innervation for
the empty function. Multiple conditions will affect the function, like old
age, spinal cord injury, infection, and bladder outlet obstruction. The
detrusor muscle become hypocontractile and fail to empty. However, the
certain pathogenesis is unknown. Urinary retention is a common sign in
the patients with hypotonic bladder. We present a 65-year-old male with
asymptomatic giant atonic bladder who only complained with abdominal
fullness. The CT revealed an enlarged prostate, and an extremely distended
bladder to pancreatic level and the volume was estimated more than
5000mL.
NDP055:
A GIANT PAPILLARY TRANSITIONAL CELL CACINOMA OF THE DISTAL
THIRD URETER WITH PROLAPSE INTO BLADDER d A RARE
CONDITION CAUSE BLADDER OUTLET OBSTRUCTION
Tsung-Wei Wang, Jia-Long Guo, Jyun-Yan He. Division of Urology,
Departments of Surgery, Puli Branch, Taichung Veterans General Hospital,
Taiwan
Case Report: A 72-year-old man was visited emergent department with
the chief complaints of dysuria, frequency urination, lower abdominal
distension and gross hematuria. Abdominal sonography disclosed one soft
tissue lesion over bladder outlet region and right hydroureteronephrosis.
Cystourethroscopy with ureteroscopy, which showed one frondlike
papillary projection from right ureteric oriﬁce was performed and biopsy
was done. The pathologic examination ﬁnding was high grade transitional
cell carcinoma. Further laparoscopic nephroureterectomy was performed
at next admission.
Although a ureteral urothelial cell carcinoma is not rare, this case is
interesting for differentiated diagnosis of low urinary tract symptoms by
sonography in elderly man at emergent department.
NDP056:
NEW MULTIPULSE® LASER PROSTATECTOMY FOR BENIGN PROSTATE
HYPERPLASIA: PRILIMINARY EXPERIENCE IN SHIN KONG MEMORIAL
HOSPITAL
Yi-Bo Chu 1, Tzu-Hsiang Wu 1, Yi-Chia Lin 1,2, Te-Fu Tsai 1,2, Hung-En Chen 1,
Yi-Hung Cheng 1, Guang-Dar Juang 1,2, Thomas I.S. Hwang 1,2. 1Division of
Urology, Department of Surgery, Shin-Kong WHS Memorial Hospital, Taipei,
Taiwan; 2Department of Urology, Fu Jen Catholic University School of
Medicine, Taipei, Taiwan
Purpose: Transurethral resection of the prostate (TURP) is the gold stan-
dard procedure for the surgical treatment of benign prostate hyperplasia
with bladder outﬂow obstruction, and the invention of laser modality used
in TUR-P improves the outcomes and reduce the morbidity. MultiPulse®
Tm+1470 laser is a new laser modality which combines Thulium:YAG
120W and Module 30W (1940nm +1470nm). We herein report the out-
comes of MultiPulse® laser TUR-P for BPH in our institution.
Materials and Methods: From 2015 October to 2016 March, 36 patients
with BPH has received MultiPulse® laser TUR-P. Demographics, size of
prostate, PSA, operation time and post-op complicationswere collected
with a retrospective medical record review. Moreover, the previous data of
patients who underwent conventional TURP and Thulium or Diode laser
prostatectomy in our hospital are compared.
Results: Among the 36 patients, the mean age was 70.2 ion time and post-
op complicationswere collected with a retrospective medical record
Abstracts / Urological Science 27 (2016) S53eS83 S67review. ne was 35.04 ± 22.24gm. The mean PSA level was 12.69± The m,
and two cases of prostate adenocarcinoma were found. The mean opera-
tive time was 111.83± and t minutes, and 25.11±minutesgm of specimen
was collected. The mean days of hospital stay was 5.69±m3.02 days, and
5.29± days, and 5.29 as collected. The mean days of hospital stay was 5.69
ive time was 111.83 ted with a o post-op blood transfusion was given. No
post-op urine retention was noted. The resected weight of prostate is
larger than previous 2 groups, however, length of hospital stay is not
signiﬁcant among the 3 groups.
Conclusion: The new laser modality, MultiPulse® Tm+1470 laser, is
available for TUR-P, and the result is comparable with previous laser
prostatectomy. Further study with larger patients group and long-term
follow-up is mandutory.
NDP057:
5-ALPHA-REDUCTASE INHIBITORS AND RISK OF DIABETES MELLITUS
Teng-Fu Hsieh 1,2, Shang-Sen Lee 1,2, Tien-Huang Lin 1,2, Hsin-Ho Liu 1,2,
Tsung-Hsun Tsai 1,2, Chi-Cheng Chen 1,2. 1Department of Urology, Taichung
Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung, Taiwan;
2 School of Medicine, Tzu Chi University, Hualian, Taiwan
Purpose: The aim of this study is to investigate the risk of diabetesmellitus
(DM) after 5-alpha-reductase inhibitor (5ARI) therapy for benign prostate
hyperplasia (BPH) using the National Health Insurance Research Database
(NHIRD) in Taiwan.
Materials and Methods: In total, 1298 adult patients newly diagnosed
with BPH and who used more than 28 cumulative deﬁned daily doses
(cDDD) of 5ARI were recruited as the therapy group cohort, along with
12887 subjects who did not use more than 28 cDDD of 5ARI as a control
group from 2002 to 2009. Each patient was monitored for ﬁve years (from
2003 to 2008) to identify those who subsequently developed DM. A Cox
proportional hazards model was used to compare the risk of DM between
the study and comparison cohorts after adjusting for possible confounding
risk factors.
Results: Patients who received 5ARI therapy had a lower cumulative rate
of DM than those who did not receive 5ARI during the ﬁve-year follow-up
period (3.5% vs. 5.3%, p¼ 0.003). In sub-group analysis, among the BPH
patients aged <65 years, the ﬁve-year DM events hazard ratio (HR) of 5ARI
users was lower than that of non-users (HR: 0.47, 95% conﬁdence interval
(CI): 0.24e0.91; p¼ 0.026).
Conclusion: Therapy with 5ARI may decrease the ﬁve-year risk of DM in
the BPH patients younger than 65 years. Further mechanistic research is
warranted to validate the results.
NDP058:
THE TOLERANCE OF TAMSULOSIN 0.4MG (HARNALIDGE® OCAS®) IN
MANAGING BENIGN PROSTATE OBSTRUCTION IN TREATMENT-NAIVE
TAIWANESE MEN
Chao-Tse Hung, Stephen Shei-Dei Yang. Division of Urology, Buddhist Tzu
Chi General Hospital, Taipei Branch, Taipei Taiwan Medical College of
Buddhist Tzu Chi University, Hualien, Taiwan
Purpose: In Taiwan, the recommended initial dosage of tamsulosin for
managing men’s lower urinary tract symptoms (LUTS) is 0.2mg per day.
The aim of the study is to evaluate the tolerance of tamsulosin 0.4mg
(Harnalidgelien, Taiwan.te the results.3). In sub-group analysis, among the
BPH patients aged <65 ye.
Material and Methods: From 2015 Jan to 2015 Dec, we retrospectively
reviewed men with LUTS suggestive of BPO visiting urologic clinics
without previous exposure to alpha blockers or 5-alpha reductase for
study. Exclusion criteria were those with urethral stricture, previous
prostate surgery, chronic kidney disease under dialysis, acute urine
retention under urethral catheterization and prostate or bladder cancer.
Baseline patient characteristics including age, international prostatic
symptom score (IPSS), total prostate volume, uroﬂowmetry and post-void
urine volume were recorded.
Results: Finally, 194 alpha-blockers naive men (mean age¼ 70.5± 14.2
years) were enrolled for analysis with. The baseline IPPS, prostate size,Qmax, PVR was 13.9± 6.3 points, 53.9± 22.8 gm, 11.5± 4.7 ml/sec, and
39.4± 33.2 mL respectively. There were only 4 shifted to the other alpha
blockers (2 silodosin and 1 tamsulosin 0.2 mg due to side effects and 1
doxazosin due to poor effect) with a mean follwup of 137± 181 days. The
Qmax and PVR improved to 12.8± 5.5 ml/sec (p¼ 0.08) and
36.2± 46.1 ml (p¼ 0.65) at 3 months followups while not statistically
signiﬁcant.
Conclusion: Tamsulosin 0.4 mg is well tolerated in alpha-blcokers na2
years) were enrolled for analysis with. The baseline IPPS, prostate size,
Qmax, PVR was 13AS® is not warranted in Taiwanese men.
NDP059:
PREVALENCE OF AND THE RISK FACTORS FOR NOCTURIA
Wei-Che Weng 1, Hui-Chen Tseng 2. 1Kaohsiung Municipal United Hospital
Department of Urology, Taiwan; 2Kaohsiung Medical University, Taiwan
Purpose: Nocturia is one of the most distressing symptoms in older men
with benign prostatic hyperplasia and is the lower urinary tract symptom
most strongly associated with poor quality of life ratings. It is associated
with increased rates of depression, work absenteeism, lower self-rated
physical and mental health, congestive heart failure, and increased all-
cause mortality. Nocturia is was noted to have higher rates of accidental
falls and fractures in the very old. There are many factors associated with
nocturia and and treatment may result in only small improvement. We
examined the prevalence of and risk factors for nocturia in North down-
town, Kaohsiung City.
Materials and Methods: We collected data on 1629 individuals with 1142
males and 487 females who living at North downtown, Kaohsiung City. We
analyze the relationships between nocturia assessed by a questionare and
other variables including age, blood pressure, Cardiovascular disease, ce-
rebrovascular disease, COPD, DM, Chronic renal failure, BPH, smoking habit
and alcohol intake.
Results: Overall, 493 individuals (30.3%) answered that they arose to
urinate at least twice during the night. The rate increased with age from
18.7 % in individuals younger than 50 to 56% in those older than 69. Logistic
regression analysis revealed that cohorts of subjects 50e59, 60e69, and 70
years old or over had, respectively, 1.82, 3.43, 5.88times the prevelance of
nocturia of the 49 years or younger cohort. Hypertention (OR 2.04), DM
(OR 1.87) and heavy smoking habit (OR 1.66) were other independent
positive factors for nocturia. In male individuals, BPH was another inde-
pendent positive risk factor (OR 1.57). Gender was not associated with
nocturia.
Conclusion: Nocturia may be caused by conditions or disorders that result
in low bladder volume voids, nocturnal polyuria, or sleep disturbances.
Age, benign prostatic hyperplasia, congestive heart failure, renal disease,
diabetes mellitus, and Hypertension are some of the conditions associated
with nocturia. Because nocturia is associated with a variety of clinical
syndromes and disorders, the diagnostic approach is often challenging,
and treatment may result in only small improvement.
Urolithiasis
NDP060:
A DIFFICULT URETER STONE, IN A PATIENT WITH ILEAL CONDUIT AND
WALLACE-TYPED URETEROILEAL ANASTOMOSIS
Ming-Hsuan Ku 1, Tzu-Ping Lin 1,2,3, Alex T.L. Lin 1,2,3, Kuang-Kuo Chen 1,2,3.
1Department of Urology, Taipei Veterans General Hospital, National Yang-
Ming University, Taiwan; 2 School of Medicine, National Yang-Ming
University, Taiwan; 3 Shu-Tien Urological Institute, National Yang-Ming
University, Taiwan
Introduction and Case Report: The two most common forms of ureter-
oenteric anastomosis after radical cystectomy and urinary diversion are the
Bricker (separate) and Wallace (conjoined) techniques. The choice usually
depends on the surgeon’s preference and experience. Reports had sug-
gested higher stricture rates with the Bricker and increased risks for bilat-
eral renal obstruction with the Wallace. On account of the difﬁculty of the
procedure, ome experts suggested it is easier to perform Bricker methods
for ureteroenteric anastomosis in patients with high body mass index.
